The purpose of this study is to study the safety of single doses and multiple doses of
Friulimicin B in healthy volunteers. The level of Friulimicin B will be measured in the
subjects blood and urine. One part of the study will assess if Friulimicin B in the plasma of
subjects has activity against bacteria.